JP2003169694A - Gram's staining reagent solution, gram's staining reagent kit, and gram's staining method using the same - Google Patents
Gram's staining reagent solution, gram's staining reagent kit, and gram's staining method using the sameInfo
- Publication number
- JP2003169694A JP2003169694A JP2001375203A JP2001375203A JP2003169694A JP 2003169694 A JP2003169694 A JP 2003169694A JP 2001375203 A JP2001375203 A JP 2001375203A JP 2001375203 A JP2001375203 A JP 2001375203A JP 2003169694 A JP2003169694 A JP 2003169694A
- Authority
- JP
- Japan
- Prior art keywords
- gram
- staining
- reagent
- anionic surfactant
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012128 staining reagent Substances 0.000 title claims abstract description 42
- 238000007447 staining method Methods 0.000 title abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 53
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 29
- 239000013078 crystal Substances 0.000 claims abstract description 23
- AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 claims abstract description 12
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000470 constituent Substances 0.000 claims abstract description 11
- 239000003495 polar organic solvent Substances 0.000 claims abstract description 7
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 38
- 238000004043 dyeing Methods 0.000 claims description 28
- 238000003794 Gram staining Methods 0.000 claims description 17
- 239000011734 sodium Substances 0.000 claims description 9
- 229940052223 basic fuchsin Drugs 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 6
- BACYUWVYYTXETD-UHFFFAOYSA-M 2-[dodecanoyl(methyl)amino]acetate Chemical compound CCCCCCCCCCCC(=O)N(C)CC([O-])=O BACYUWVYYTXETD-UHFFFAOYSA-M 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 5
- 150000004996 alkyl benzenes Chemical group 0.000 claims description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 5
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical group [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 5
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 claims description 4
- 150000008051 alkyl sulfates Chemical class 0.000 claims 3
- 229940099352 cholate Drugs 0.000 claims 3
- 229940049964 oleate Drugs 0.000 claims 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 3
- 239000000243 solution Substances 0.000 description 60
- -1 tridecanoyl group Chemical group 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 239000000523 sample Substances 0.000 description 16
- 238000010186 staining Methods 0.000 description 14
- 238000011282 treatment Methods 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 241000191967 Staphylococcus aureus Species 0.000 description 11
- 239000003240 coconut oil Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229960002989 glutamic acid Drugs 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- JUQPZRLQQYSMEQ-UHFFFAOYSA-N CI Basic red 9 Chemical compound [Cl-].C1=CC(N)=CC=C1C(C=1C=CC(N)=CC=1)=C1C=CC(=[NH2+])C=C1 JUQPZRLQQYSMEQ-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000012085 test solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 4
- 238000004042 decolorization Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 3
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 3
- 239000004380 Cholic acid Substances 0.000 description 3
- 241000193996 Streptococcus pyogenes Species 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229960003767 alanine Drugs 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 229960002471 cholic acid Drugs 0.000 description 3
- 235000019416 cholic acid Nutrition 0.000 description 3
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 3
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 229960001235 gentian violet Drugs 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
- ACCAIGJKLCJFHP-UQKRIMTDSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ACCAIGJKLCJFHP-UQKRIMTDSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- JCIQMOUUPOJKRD-WNQIDUERSA-N (2S)-2-aminopropanoic acid 2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound C[C@H](N)C(O)=O.OCCN(CCO)CCO JCIQMOUUPOJKRD-WNQIDUERSA-N 0.000 description 1
- MTJZWYHTZFVEGI-INIZCTEOSA-N (2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O MTJZWYHTZFVEGI-INIZCTEOSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- ATFFFUXLAJBBDE-FQEVSTJZSA-N N-Stearoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ATFFFUXLAJBBDE-FQEVSTJZSA-N 0.000 description 1
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 101100516878 Staphylococcus aureus nos gene Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000000981 basic dye Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 125000000628 margaroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- URLJMZWTXZTZRR-UHFFFAOYSA-N sodium myristyl sulfate Chemical compound CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 description 1
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000000297 undecanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Landscapes
- Sampling And Sample Adjustment (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、保存安定性に優れ
たグラム染色用前染色試液、これを構成試薬として含ん
でなるグラム染色用試薬キット、及びグラム染色の改良
法に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a pre-staining reagent solution for Gram staining having excellent storage stability, a reagent kit for Gram staining containing the same as a constituent reagent, and an improved method for Gram staining.
【0002】[0002]
【従来の技術】グラム染色法は、組織中に存在する細菌
を染め分けるために考案されたものであるが、手技が簡
単であり且つ経済的で、染色手技及び標本の鏡検に熟練
すれば感染症起炎菌の推測が可能なことから、現在では
臨床的価値の高い迅速検査法の1つとなっている。2. Description of the Related Art The Gram staining method was devised to stain bacteria present in tissues, but the procedure is simple and economical, and if one is skilled in staining procedures and microscopic examination of specimens. Since it is possible to infer the causative agent of infectious disease, it is currently one of the rapid test methods with high clinical value.
【0003】グラム染色法としては、前染色色素として
石炭酸ゲンチアンバイオレットを用いたハッカー(Huck
er)原法が知られているが、この方法は染色中に色素で
ある石炭酸ゲンチアンバイオレットが晶析してしまう等
の問題を有することから、現在では、石炭酸ゲンチアン
バイオレットの代わりにクリスタルバイオレットを前染
色色素として用いたハッカーの変法が一般的に使用され
ている。As a Gram dyeing method, a hacker (Huck) using Gentian violet carbonate as a pre-dying dye is used.
er) Although the original method is known, this method has problems such as the fact that the pigment gentian violet, a pigment, is crystallized during dyeing, so at present, instead of the carboxylic acid gentian violet, crystal violet is used. A modified hacker method is generally used in which is used as a pre-staining dye.
【0004】この方法は、試料中のグラム陽性菌及びグ
ラム陰性菌を、シュウ酸アンモニウム含有クリスタル
バイオレット溶液で1分間染色(前染色処理)した後、
ルゴール液(ヨウ素−ヨウ化カリウム液)を数回かけ
て1分間媒染(媒染処理)し、次いで純エタノールで
塗抹面が無色になるまで30秒〜1分間脱色(脱色処理)
し、更にサフラニン液で1分間対比染色(後染色処
理)することにより、クリスタルバイオレット由来の赤
紫色に染まったグラム陽性菌とサフラニン由来の赤色に
染まったグラム陰性菌を識別する方法であるが、染色手
技に熟練を要するため、染色結果に個人差が生じてしま
い判定結果が正確でないという問題点を有している。According to this method, Gram-positive and Gram-negative bacteria in a sample are stained with ammonium oxalate-containing crystal violet solution for 1 minute (pre-staining treatment), and then,
Lugol solution (iodine-potassium iodide solution) is mordanted for several minutes (mordanting treatment) several times, and then decolorized with pure ethanol for 30 seconds to 1 minute until the smeared surface becomes colorless (decolorization treatment).
Then, by further counterstaining (post-staining treatment) with a safranin solution for 1 minute, a gram-positive bacterium stained with magenta from crystal violet and a gram-negative bacterium stained with red from safranin are distinguished. Since the dyeing technique requires skill, there is a problem that the determination result is inaccurate because individual differences occur in the dyeing result.
【0005】これに対して、前染色試液に炭酸水素ナト
リウムを添加することで溶液を塩基性に保ち、クリスタ
ルバイオレット(塩基性色素)の染色性を向上させたBa
rtholomew&Mittwer法(バーミー法)があるが、この方
法は、1%クリスタルバイオレット液を注ぎ、直ちに
5%炭酸水素ナトリウム液を数滴滴下し30秒間染色(前
染色処理)した後、2%ヨウ素液(0.1N水酸化ナト
リウム溶液)で30秒間媒染(媒染処理)し、次いでア
セトン−エタノール混合液で塗抹面が無色になるまで数
秒間脱色(脱色処理)し、更にパイフェル液で10〜30
秒間対比染色(後染色処理)することにより、当該グラ
ム陽性菌とグラム陰性菌を識別する方法である。ハッカ
ー変法と比較すると、前染色処理が1工程多いが、全体
の染色時間は短く、また脱色処理にアセトン−エタノー
ル混合液を用いるため処理時間が数秒程度であり手技に
よる差が少なく正確な判定が可能であるという利点を有
する。しかし、前染色試液である、クリスタルバイオレ
ット液と炭酸水素ナトリウム液を混合して保存すると、
時間の経過と共に結晶が析出してきて染色性が悪くなる
ことが知られている。そのため、キット化するには、こ
れらを2液とし、使用時に適宜混合するという方式を採
用せざるを得なかった。しかしながら、グラム染色の自
動化への対応を考えた場合、この2液化された前染色試
液の使用は好ましいものではなかった。On the other hand, by adding sodium hydrogencarbonate to the pre-dyeing test solution, the solution is kept basic, and the dyeability of crystal violet (basic dye) is improved.
There is the rtholomew & Mittwer method (Burmy method). This method is to pour 1% crystal violet solution, immediately drop a few drops of 5% sodium hydrogen carbonate solution, stain for 30 seconds (pre-staining treatment), and then add 2% iodine solution ( Mordant with 0.1N sodium hydroxide solution for 30 seconds (mordanting treatment), then decolorize with acetone-ethanol mixture for several seconds until the smeared surface becomes colorless (bleaching treatment), and further with Peifel solution for 10-30
This is a method of distinguishing the gram-positive bacterium from the gram-negative bacterium by performing counterstaining (post-staining treatment) for seconds. Compared with the Hacker modified method, the pre-staining process has one more step, but the overall dyeing time is short, and the processing time is about several seconds because the acetone-ethanol mixed solution is used for the decolorization process, and there is little difference due to the procedure and accurate determination. Has the advantage that However, when the crystal violet solution, which is the pre-staining reagent solution, and the sodium hydrogen carbonate solution are mixed and stored,
It is known that crystals are deposited with the passage of time and the dyeability deteriorates. Therefore, in order to prepare a kit, there was no choice but to employ a method in which these were made into two liquids and mixed appropriately at the time of use. However, in consideration of the automation of Gram's staining, the use of this two-liquefied pre-staining reagent solution was not preferable.
【0006】これに対して、前染色試液を1液化したバ
ーミー法の変法(商品名:バーミーM染色、武藤化学
(株)社製)があるが、この方法では、グラム陰性菌で
染まりにくい菌があり染色性がよくない等の問題点を有
する。On the other hand, there is a modified version of the Burmy method in which the pre-staining reagent solution is liquefied (trade name: Burmy M stain, manufactured by Muto Kagaku Co., Ltd.), but this method does not stain with Gram-negative bacteria. There are problems such as the presence of bacteria and poor dyeability.
【0007】このような状況下、染色性がよく、前染色
試液の保存安定性に富み、且つ自動機器への対応が可能
な1液化された前染色試液の開発及びこれを用いたグラ
ム染色の改良法が望まれる現状にある。Under these circumstances, the development of a one-part pre-staining reagent solution having good dyeability, excellent storage stability of the pre-staining reagent solution and compatible with automatic equipment, and Gram stain using the same The current situation is that improved methods are desired.
【0008】[0008]
【発明が解決しようとする課題】本発明は、上記した如
き状況に鑑みなされたもので、保存安定性に優れたグラ
ム染色用前染色試液、これを構成試薬として含んでなる
グラム染色用試薬キット、及びグラム染色の改良法を提
供することを課題とする。SUMMARY OF THE INVENTION The present invention has been made in view of the above situation, and is a pre-staining reagent solution for gram staining excellent in storage stability, and a gram staining reagent kit containing the same as a constituent reagent. And to provide an improved method of Gram stain.
【0009】[0009]
【課題を解決するための手段】本発明は、クリスタルバ
イオレットと陰イオン界面活性剤とを含んでなるグラム
染色用前染色試液、の発明である。The present invention is an invention of a pre-staining reagent solution for Gram stain which comprises crystal violet and an anionic surfactant.
【0010】また、本発明は、クリスタルバイオレット
と陰イオン界面活性剤とを含んでなるグラム染色用前染
色試液を構成試薬として含んでなる、グラム染色用試薬
キット、の発明である。Further, the present invention is an invention of a reagent kit for Gram staining, which comprises a pre-staining reagent solution for Gram staining containing crystal violet and an anionic surfactant as a constituent reagent.
【0011】更に、本発明は、試料を、クリスタルバイ
オレットと陰イオン界面活性剤とを含んでなる前染色試
液で処理した後、ヨウ素を含んでなる媒染試液で処理
し、次いで極性有機溶媒を含んでなる脱色試液で処理
し、更にサフラニン、石炭酸フクシン又は塩基性フクシ
ンを含んでなる後染色試液で処理することを特徴とす
る、グラム染色法、の発明である。Further, in the present invention, a sample is treated with a pre-dyeing reagent containing crystal violet and an anionic surfactant, and then with a mordant reagent containing iodine, and then with a polar organic solvent. The invention of the Gram dyeing method is characterized in that treatment is carried out with a decolorizing reagent which comprises: and further a post-dyeing reagent containing safranine, fuchsin carbonate or basic fuchsin.
【0012】即ち、本発明者等は、上記の目的を達成す
べく鋭意研究を重ねた結果、陰イオン界面活性剤を含有
するグラム染色用前染色試液を用いてグラム染色を行う
ことにより、従来のグラム染色法が有する、前染色試液
が2液化されているため自動機器に対応できない、この
2液化された前染色試液を混合すると結晶が析出してし
まい染色性が悪くなる等の欠点を克服し、1液化された
前染色試液を用いることによる自動機器への対応が可能
となり、またこの1液化された前染色試液を用いれば結
晶を生じずに保存安定性に優れ、且つ染色性に優れた染
色像が得られることを見出し、本発明を完成するに至っ
た。That is, the inventors of the present invention have conducted extensive studies to achieve the above object, and as a result, by performing Gram dyeing using a pre-dyeing reagent solution for Gram dyeing containing an anionic surfactant, Overcome the disadvantages of Gram's staining method, such as the fact that the pre-dyeing reagent solution is liquefied and cannot be used for automatic equipment, and that when this liquefied pre-dyeing reagent solution is mixed, crystals precipitate and the dyeability deteriorates. However, it is possible to support automatic equipment by using a pre-staining reagent solution that has been liquefied. Also, if this pre-staining reagent solution that has been liquefied is used, storage stability is excellent without crystallization and excellent dyeability. The inventors have found that a dyed image can be obtained and completed the present invention.
【0013】本発明に使用する陰イオン界面活性剤とし
ては、例えばN-アシルグルタミン酸、N-アシルアラニ
ン、N-アシルグリシン、これらの塩等のアミノ酸系陰イ
オン界面活性剤、例えばアルキルベンゼンスルホン酸、
アルキル硫酸、オレイン酸、コール酸、N-ドデカノイル
サルコシン酸、これらの塩等が挙げられ、中でもN-ドデ
カノイルサルコシン酸、N-アシルグルタミン酸、コール
酸、これらの塩等が好ましく、就中、N-ドデカノイルサ
ルコシン酸塩がより好ましい。これらは夫々単独で用い
ても、二種以上を適宜組み合わせて用いてもよい。Examples of the anionic surfactant used in the present invention include amino acid type anionic surfactants such as N-acyl glutamic acid, N-acyl alanine, N-acyl glycine and salts thereof, for example, alkylbenzene sulfonic acid,
Alkylsulfuric acid, oleic acid, cholic acid, N-dodecanoyl sarcosinic acid, salts thereof, and the like, among them, N-dodecanoyl sarcosinic acid, N-acyl glutamic acid, cholic acid, preferable salts thereof, among others, among others, More preferred is N-dodecanoyl sarcosinate. These may be used alone or in appropriate combination of two or more.
【0014】アミノ酸系陰イオン界面活性剤として挙げ
られるN-アシルグルタミン酸、N-アシルアラニン及びN-
アシルグリシン中のアシル基としては、直鎖状、分枝状
或いは環状でもよく、通常炭素数6〜18、好ましくは
炭素数12〜18のものが挙げられ、具体的には、例え
ばヘキサノイル基、ヘプタノイル基、オクタノイル基、
ノナノイル基、デカノイル基、ウンデカノイル基、ラウ
ロイル基、トリデカノイル基、ミリストイル基、ペンタ
デカノイル基、パルミトイル基、ヘプタデカノイル基、
ステアロイル基等が挙げられ、中でも、例えばラウロイ
ル基、ミリストイル基、パルミトリル基、ステアロイル
基等が好ましい。N-acyl glutamic acid, N-acyl alanine and N-, which are mentioned as amino acid-based anionic surfactants
The acyl group in acylglycine may be linear, branched or cyclic, and usually has 6 to 18 carbon atoms, preferably 12 to 18 carbon atoms, and specifically, for example, a hexanoyl group, Heptanoyl group, octanoyl group,
Nonanoyl group, decanoyl group, undecanoyl group, lauroyl group, tridecanoyl group, myristoyl group, pentadecanoyl group, palmitoyl group, heptadecanoyl group,
Examples thereof include stearoyl group, and among them, for example, lauroyl group, myristoyl group, palmitolyl group, stearoyl group and the like are preferable.
【0015】アルキルベンゼンスルホン酸及びアルキル
硫酸中のアルキル基としては、直鎖状、分枝状或いは環
状でもよく、通常炭素数8〜18、好ましくは10〜1
4のものが挙げられ、具体的には、例えばn−オクチル
基、イソオクチル基、sec-オクチル基、tert-オクチル
基、ネオオクチル基、n−ノニル基、イソノニル基、se
c-ノニル基、tert-ノニル基、ネオノニル基、n−デシ
ル基、イソデシル基、sec-デシル基、tert-デシル基、
ネオデシル基、n−ウンデシル基、イソウンデシル基、
sec-ウンデシル基、tert-ウンデシル基、ネオウンデシ
ル基、n−ドデシル基、イソドデシル基、sec-ドデシル
基、tert-ドデシル基、ネオドデシル基、n−トリデシ
ル基、イソトリデシル基、sec-トリデシル基、tert-ト
リデシル基、ネオトリデシル基、n−テトラデシル基、
イソテトラデシル基、sec-テトラデシル基、tert-テト
ラデシル基、ネオテトラデシル基、n−ペンタデシル
基、イソペンタデシル基、sec-ペンタデシル基、tert-
ペンタデシル基、ネオペンタデシル基、n−ヘキサデシ
ル基、イソへキサデシル基、sec-へキサデシル基、tert
-へキサデシル基、ネオへキサデシル基、n−ヘプタデ
シル基、イソヘプタデシル基、sec-ヘプタデシル基、te
rt-ヘプタデシル基、ネオヘプタデシル基、n−オクタ
デシル基、イソオクタデシル基、sec-オクタデシル基、
tert-オクタデシル基、ネオオクタデシル基等が挙げら
れ、中でも、例えば炭素数10〜14のものが好まし
く、就中、n−ドデシル基が特に好ましい。The alkyl group in alkylbenzenesulfonic acid and alkylsulfuric acid may be linear, branched or cyclic, and usually has 8 to 18 carbon atoms, preferably 10 to 1 carbon atoms.
4, specifically, for example, n-octyl group, isooctyl group, sec-octyl group, tert-octyl group, neooctyl group, n-nonyl group, isononyl group, se
c-nonyl group, tert-nonyl group, neononyl group, n-decyl group, isodecyl group, sec-decyl group, tert-decyl group,
Neodecyl group, n-undecyl group, isoundecyl group,
sec-undecyl group, tert-undecyl group, neoundecyl group, n-dodecyl group, isododecyl group, sec-dodecyl group, tert-dodecyl group, neododecyl group, n-tridecyl group, isotridecyl group, sec-tridecyl group, tert-tridecyl group Group, neotridecyl group, n-tetradecyl group,
Isotetradecyl group, sec-tetradecyl group, tert-tetradecyl group, neotetradecyl group, n-pentadecyl group, isopentadecyl group, sec-pentadecyl group, tert-
Pentadecyl group, neopentadecyl group, n-hexadecyl group, isohexadecyl group, sec-hexadecyl group, tert
-Hexadecyl group, neohexadecyl group, n-heptadecyl group, isoheptadecyl group, sec-heptadecyl group, te
rt-heptadecyl group, neoheptadecyl group, n-octadecyl group, isooctadecyl group, sec-octadecyl group,
Examples thereof include a tert-octadecyl group and a neooctadecyl group. Among them, those having 10 to 14 carbon atoms are preferable, and among them, n-dodecyl group is particularly preferable.
【0016】N-アシルグルタミン酸、N-アシルアラニ
ン、N-アシルグリシン、アルキルベンゼンスルホン酸、
アルキル硫酸、オレイン酸、コール酸、N-ドデカノイル
サルコシン酸の塩としては、例えばリチウム、ナトリウ
ム、カリウム等のアルカリ金属塩、トリエタノールアミ
ン塩等が挙げられ、中でもナトリウムが好ましい。N-acyl glutamic acid, N-acyl alanine, N-acyl glycine, alkylbenzene sulfonic acid,
Examples of the salts of alkylsulfuric acid, oleic acid, cholic acid and N-dodecanoylsarcosinic acid include alkali metal salts such as lithium, sodium and potassium, triethanolamine salts and the like, with sodium being preferred.
【0017】アミノ酸系陰イオン界面活性剤として挙げ
られるN-アシルグルタミン酸及びその塩の具体例として
は、例えばN-ヤシ油脂肪酸アシル-L-グルタミン酸トリ
エタノールアミン〔商品名:アミソフト(R)CT−1
2、味の素(株)社製〕、N-ラウロイル−グルタミン酸
トリエタノールアミン〔商品名:アミソフト(R)LT
−12、味の素(株)社製〕、N-ヤシ油脂肪酸アシル-L
-グルタミン酸カリウム〔商品名:アミソフト(R)C
K−12、味の素(株)社製〕、N-ヤシ油脂肪酸アシル
-L-グルタミン酸ナトリウム〔商品名:アミソフト
(R)CS−11、味の素(株)社製〕、N-ラウロイル
-L-グルタミン酸ナトリウム〔商品名:アミソフト
(R)LS−11、味の素(株)社製〕、ミリストイル
-L-グルタミン酸ナトリウム〔商品名:アミソフト
(R)MS−11、味の素(株)社製〕、N-ミリストリ
ル-L-グルタミン酸カリウム〔商品名:アミソフト
(R)MK−11、味の素(株)社製〕、N-ステアロイ
ル-L-グルタミン酸二ナトリウム〔商品名:アミソフト
(R)HS−11、味の素(株)社製〕、N-ステアロイ
ル-L-グルタミン酸二ナトリウム〔商品名:アミソフト
(R)HS−11、味の素(株)社製〕、N-ヤシ油脂肪
酸アシル-L-グルタミン酸〔商品名:アミソフト(R)
CA、味の素(株)社製〕、N-ラウロイル-L-グルタミ
ン酸〔商品名:アミソフト(R)LA、味の素(株)社
製〕、N-ミリストイル-L-グルタミン酸〔商品名:アミ
ソフト(R)MA、味の素(株)社製〕、N-ステアロイ
ル-L-グルタミン酸〔商品名:アミソフト(R)HA、
味の素(株)社製〕等が挙げられ、中でも、N-ヤシ油脂
肪酸アシル-L-グルタミン酸トリエタノールアミン〔商
品名:アミソフト(R)CT−12、味の素(株)社
製〕、N-ラウロイル−グルタミン酸トリエタノールアミ
ン〔商品名:アミソフト(R)LT−12、味の素
(株)社製〕、N-ヤシ油脂肪酸アシル-L-グルタミン酸
ナトリウム〔商品名:アミソフト(R)CS−11、味
の素(株)社製〕、ミリストイル-L-グルタミン酸ナト
リウム〔商品名:アミソフト(R)MS−11、味の素
(株)社製〕等が好ましい。Specific examples of N-acyl glutamic acid and salts thereof which can be mentioned as amino acid anionic surfactants include, for example, N-coconut oil fatty acid acyl-L-glutamic acid triethanolamine [trade name: Amisoft (R) CT- 1
2, Ajinomoto Co., Inc.], N-lauroyl-glutamic acid triethanolamine [trade name: Amisoft (R) LT
-12, manufactured by Ajinomoto Co., Inc.], N-coconut oil fatty acid acyl-L
-Potassium glutamate [Product name: Amisoft (R) C
K-12, manufactured by Ajinomoto Co., Inc.], N-coconut oil fatty acid acyl
-Sodium L-glutamate [trade name: Amisoft (R) CS-11, manufactured by Ajinomoto Co., Inc.], N-lauroyl
-Sodium L-glutamate [trade name: Amisoft (R) LS-11, manufactured by Ajinomoto Co., Inc.], myristoyl
-L-Glutamate sodium [trade name: Amisoft (R) MS-11, manufactured by Ajinomoto Co., Inc.], N-myristolyl-L-glutamate potassium [trade name: Amisoft (R) MK-11, Ajinomoto Co., Inc. ], N-stearoyl-L-glutamate disodium [trade name: Amisoft (R) HS-11, Ajinomoto Co., Inc.], N-stearoyl-L-glutamate disodium [trade name: Amisoft (R) HS -11, manufactured by Ajinomoto Co., Inc.], N-coconut oil fatty acid acyl-L-glutamic acid [trade name: Amisoft (R)]
CA, manufactured by Ajinomoto Co., Inc.], N-lauroyl-L-glutamic acid [trade name: Amisoft (R) LA, manufactured by Ajinomoto Co.], N-myristoyl-L-glutamic acid [trade name: Amisoft (R)] MA, manufactured by Ajinomoto Co., Inc.], N-stearoyl-L-glutamic acid [trade name: Amisoft (R) HA,
Ajinomoto Co., Inc.] and the like, and among them, N-coconut oil fatty acid acyl-L-glutamic acid triethanolamine [trade name: Amisoft (R) CT-12, Ajinomoto Co., Inc.], N-lauroyl -Glutamic acid triethanolamine [trade name: Amisoft (R) LT-12, manufactured by Ajinomoto Co., Inc.], N-coconut oil fatty acid acyl-L-glutamate sodium [Product name: Amisoft (R) CS-11, Ajinomoto ( Co., Ltd.], myristoyl-L-sodium glutamate [trade name: Amisoft (R) MS-11, Ajinomoto Co., Inc.] and the like are preferable.
【0018】アミノ酸系陰イオン界面活性剤として挙げ
られるN-アシルアラニン、N-アシルグリシン及びその塩
の具体例としては、例えばN-ヤシ油脂肪酸アシルグリシ
リンカリウム〔商品名:アミライト(R)GCK−11
(F)、味の素(株)社製〕、N-ヤシ油脂肪酸アシル-D
L-アラニントリエタノールアミン〔商品名:アミライト
(R)ACT−12、味の素(株)社製〕等が挙げられ
る。Specific examples of N-acylalanine, N-acylglycine and salts thereof which can be mentioned as the amino acid anionic surfactant include, for example, N-coconut oil fatty acid acylglycillin potassium [trade name: Amilite (R) GCK]. -11
(F), manufactured by Ajinomoto Co., Inc.], N-coconut oil fatty acid acyl-D
L-alanine triethanolamine [trade name: Amilite (R) ACT-12, manufactured by Ajinomoto Co., Inc.] and the like can be mentioned.
【0019】本発明に係る陰イオン界面活性剤のより好
ましい具体例としては、例えばN-ドデカノイルサルコシ
ン酸ナトリウム、コール酸ナトリウム、ドデシル硫酸ナ
トリウム、ドデシルスルホン酸ナトリウム、ドデシルベ
ンゼンスルホン酸ナトリウム、テトラデシル硫酸ナトリ
ウム等が挙げられ、更に好ましいものとしては、N-ドデ
カノイルサルコシン酸ナトリウムが挙げられる。More preferred specific examples of the anionic surfactant according to the present invention include sodium N-dodecanoyl sarcosinate, sodium cholate, sodium dodecyl sulfate, sodium dodecyl sulfonate, sodium dodecyl benzene sulfonate, and tetradecyl sulfate. Examples thereof include sodium, and more preferable examples include sodium N-dodecanoylsarcosinate.
【0020】本発明に係るグラム染色用前染色試液とし
ては、上記した如き陰イオン界面活性剤とクリスタルバ
イオレットを低級アルコール含有水溶液に溶解させたも
のが挙げられる。Examples of the pre-dyeing reagent solution for Gram dyeing according to the present invention include those in which an anionic surfactant and crystal violet as described above are dissolved in a lower alcohol-containing aqueous solution.
【0021】当該クリスタルバイオレットの前染色試液
中の濃度は、通常0.05〜2w/v%、好ましくは0.2〜0.6w
/v%である。The concentration of the crystal violet in the pre-staining reagent solution is usually 0.05 to 2 w / v%, preferably 0.2 to 0.6 w.
/ v%.
【0022】当該陰イオン界面活性剤の前染色試液中の
濃度は、通常0.02〜5v/v%、好ましくは0.05〜0.25v/v
%である。The concentration of the anionic surfactant in the pre-staining reagent solution is usually 0.02 to 5 v / v%, preferably 0.05 to 0.25 v / v.
%.
【0023】当該低級アルコールとしては、クリスタル
バイオレット及び陰イオン界面活性剤を溶解するもので
あれば特に限定されないが、通常炭素数1〜4のものが
挙げられ、具体的には、例えばメタノール、エタノー
ル、n-プロパノール、イソプロパノール、n−ブタノー
ル、イソブタノール、sec-ブタノール、tert-ブタノー
ル等が挙げられ、中でもメタノール、エタノール、イソ
プロピルアルコールが好ましく、就中、エタノールがよ
り好ましい。これらは夫々単独で用いても、二種以上適
宜組み合わせて用いてもよい。The lower alcohol is not particularly limited as long as it dissolves crystal violet and an anionic surfactant, and usually includes ones having 1 to 4 carbon atoms, specifically, for example, methanol and ethanol. , N-propanol, isopropanol, n-butanol, isobutanol, sec-butanol, tert-butanol, and the like, among which methanol, ethanol, and isopropyl alcohol are preferable, and ethanol is more preferable. These may be used alone or in appropriate combination of two or more kinds.
【0024】当該前染色試液中の低級アルコール濃度
は、通常1〜40v/v%、好ましくは15〜25v/v%である。The lower alcohol concentration in the pre-dyeing reagent solution is usually 1 to 40 v / v%, preferably 15 to 25 v / v%.
【0025】また、当該前染色試液中には、緩衝剤を通
常pH5.5〜9.0、好ましくはpH6.0〜7.0となるように
適宜添加させることが好ましい。In addition, it is preferable to appropriately add a buffer to the pre-dyeing reagent solution so that the pH is usually 5.5 to 9.0, preferably 6.0 to 7.0.
【0026】当該緩衝剤の具体例としては、例えばBis
(2-ヒドロキシエチル)イミノトリス(ヒドロキシメチル)
メタン(Bis−Tris)、2-モルホリノエタンスル
ホン酸(MES)、N,N-ビス(2-ヒドロキシエチル)-2-
アミノエタンスルホン酸(BES)、トリス(ヒドロキ
シメチル)アミノメタン(Tris)、ピペラジン-1,4-
ビス(2-エタンスルホン酸)(PIPES)、3-モルホリ
ノプロパンスルホン酸(MOPS)、N-トリス(ヒドロ
キシメチル)メチル-2-アミノエタンスルホン酸(TE
S)等のグッド緩衝剤、リン酸緩衝生理食塩水(PB
S)等が挙げられ、中でもBis−Tris、MES、
BES、PBS等が好ましい。これらは夫々単独で用い
ても、二種以上適宜組み合わせて用いてもよい。Specific examples of the buffering agent include Bis
(2-hydroxyethyl) iminotris (hydroxymethyl)
Methane (Bis-Tris), 2-morpholinoethanesulfonic acid (MES), N, N-bis (2-hydroxyethyl) -2-
Aminoethanesulfonic acid (BES), tris (hydroxymethyl) aminomethane (Tris), piperazine-1,4-
Bis (2-ethanesulfonic acid) (PIPES), 3-morpholinopropanesulfonic acid (MOPS), N-tris (hydroxymethyl) methyl-2-aminoethanesulfonic acid (TE
Good buffer such as S), phosphate buffered saline (PB
S) and the like, among which Bis-Tris, MES,
BES, PBS and the like are preferred. These may be used alone or in appropriate combination of two or more kinds.
【0027】本発明に係るグラム染色用試薬キットは、
上記の如きグラム染色用前染色試液を構成試薬として含
んでなるものであり、具体的には、更に、ヨウ素を含ん
でなる媒染試液、極性有機溶媒を含んでなる脱色試液、
及びサフラニン、石炭酸フクシン又は塩基性フクシンを
含んでなる後染色試液を構成試薬として含んでなるもの
である。The Gram stain reagent kit according to the present invention comprises:
A pre-staining reagent solution for Gram staining as described above is contained as a constituent reagent, and more specifically, a mordant reagent solution containing iodine, a decolorizing reagent solution containing a polar organic solvent,
And a post-staining reagent solution containing safranine, fuchsin phenate or basic fuchsin as a constituent reagent.
【0028】ヨウ素を含んでなる媒染試液としては、通
所この分野で使用されるもの、例えばBartholomew&Mit
twerの変法で使用されるもの等が好ましく挙げられ、こ
れを調製する場合には、ヨウ素を例えば水酸化ナトリウ
ム水溶液等の塩基性水溶液に溶解させたもの等が挙げら
れる。As the mordant reagent containing iodine, those commonly used in this field, for example, Bartholomew & Mit
Preferred are those used in the modified Twer's method, and in the case of preparing this, those obtained by dissolving iodine in a basic aqueous solution such as an aqueous solution of sodium hydroxide can be mentioned.
【0029】当該ヨウ素の媒染試液中の濃度としては、
通常0.1〜0.3w/v%、好ましくは0.15〜0.25w/v%であ
り、水酸化ナトリウム等の塩基性化合物は、好ましくは
0.4〜0.8w/v%となるように適宜添加される。The concentration of the iodine in the mordant reagent solution is as follows:
Usually 0.1 to 0.3 w / v%, preferably 0.15 to 0.25 w / v%, and basic compounds such as sodium hydroxide are preferably
It is appropriately added so as to be 0.4 to 0.8 w / v%.
【0030】極性有機溶媒を含んでなる脱色試液として
は、例えばアルコール類、ケトン類又はこれらの混合溶
液が挙げられる。Examples of the decolorizing reagent containing a polar organic solvent include alcohols, ketones and mixed solutions thereof.
【0031】アルコール類としては、例えばメタノー
ル、エタノール、プロパノール、イソプロパノール、2-
ブタノール等が挙げられ、中でもメタノール、エタノー
ルが好ましい。Examples of alcohols include methanol, ethanol, propanol, isopropanol, 2-
Butanol and the like can be mentioned, with preference given to methanol and ethanol.
【0032】ケトン類としては、例えばアセトン、メチ
ルエチルケトン、γ-ブチロラクトン等が挙げられ、中
でもアセトンが好ましい。Examples of the ketones include acetone, methyl ethyl ketone, γ-butyrolactone, etc., among which acetone is preferred.
【0033】これらの混合溶液としては、例えばエタノ
ールとアセトンの混合溶液が好ましく挙げられる。The mixed solution of these is preferably a mixed solution of ethanol and acetone.
【0034】脱色試液中に含まれる当該アルコール類の
濃度としては、通常40〜100v/v%、好ましくは60〜100v
/v%であり、当該ケトン類の濃度としては、通常0〜60
v/v%、好ましくは0〜40v/v%である。The concentration of the alcohol contained in the decolorization reagent is usually 40 to 100 v / v%, preferably 60 to 100 v.
/ v%, and the concentration of the ketone is usually 0 to 60
v / v%, preferably 0-40 v / v%.
【0035】本発明に係るサフラニン、石炭酸フクシン
又は塩基性フクシンを含んでなる後染色試液としては、
例えばサフラニン液、石炭酸フクシン液、パイフェル
液、塩基性フクシン液等が挙げられる。これらは、市販
のものを用いてもよいし、常法により適宜調製したもの
を通常の濃度で用いてもよい。The post-staining reagent solution containing safranine, fuchsin phenate or basic fuchsin according to the present invention is
For example, safranine solution, fuchsin folic acid solution, Peifel solution, basic fuchsin solution and the like can be mentioned. As these, commercially available products may be used, or those appropriately prepared by a conventional method may be used at a normal concentration.
【0036】尚、当該後染色試液は、試料が患者検体の
場合はサフラニン液が好ましく、純培養菌の場合には石
炭酸フクシン液、パイフェル液又は塩基性フクシン液が
好ましい。また、嫌気性グラム陰性桿菌等の染色性の弱
い菌が存在する試料の場合はパイフェル液が好ましい。The post-staining reagent solution is preferably a safranin solution when the sample is a patient sample, and is preferably a fuchsin carbonate, a Peifel solution or a basic fuchsin solution when it is a pure culture. Further, in the case of a sample in which bacteria having weak staining properties such as anaerobic Gram-negative bacillus are present, the Peifel solution is preferable.
【0037】本発明に係るグラム染色法としては、例え
ば以下の通りである。The Gram staining method according to the present invention is, for example, as follows.
【0038】先ず、試料を塗抹、乾燥させた後、アルコ
ール固定を行ったサンプルを、本発明に係る陰イオン界
面活性剤とクリスタルバイオレット溶液を含んでなる前
染色試液で4〜37℃で0.5〜1分間処理した後、ヨウ素
を含んでなる媒染試液で4〜37℃で0.5〜1分間処理
し、次いで極性有機溶媒を含んでなる脱色試液で4〜37
℃で5秒〜10秒間処理し、更にサフラニン液、石炭酸フ
クシン又は塩基性フクシンを含んでなる後染色試液で4
〜37℃で5秒〜10秒間処理すればよい。また、これらの
処理の間にサンプルを適宜水等で洗浄処理することが好
ましい。得られた染色像は、クリスタルバイオレット溶
液由来の色(紫〜黒紫色)に染色されている場合はグラ
ム陽性菌と認識され、サフラニン液又はパイフェル液由
来の色(赤色)に染色されている場合はグラム陰性菌と
認識される。First, after smearing and drying the sample, the sample fixed with alcohol is treated with a pre-staining reagent solution containing the anionic surfactant according to the present invention and a crystal violet solution at 4-37 ° C. for 0.5-0.5%. After treating for 1 minute, it is treated with a mordant reagent containing iodine for 0.5 to 1 minute at 4 to 37 ° C, and then a decolorizing reagent containing a polar organic solvent for 4 to 37 minutes.
After treatment at 5 ° C for 10 seconds, safranine solution, fuchsin phenate, or basic fuchsin is added to the dyeing test solution.
It suffices to perform the treatment at 37 ° C for 5 seconds to 10 seconds. In addition, it is preferable to appropriately wash the sample with water or the like between these treatments. The obtained stained image is recognized as a Gram-positive bacterium when it is stained with a crystal violet solution-derived color (purple to black-purple), and when it is stained with a safranine solution or a Paifel solution-derived color (red) Is recognized as a Gram-negative bacterium.
【0039】これらの試液中の構成要素の具体例、濃度
等の好ましい態様は、上記した通りである。The preferred embodiments such as specific examples and concentrations of the constituents in these test solutions are as described above.
【0040】以下に実施例及び比較例を挙げて本発明を
更に詳細に説明するが、本発明はこれらにより何ら限定
されるものではない。Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto.
【0041】[0041]
【実施例】実施例1.
〔サンプル作製〕グラム染色で染まりにくいといわれる
グラム陽性菌である、純培養菌2種4例〔黄色ブドウ球
菌(Staphylococcus aureus):No.37,352、
化膿性連鎖球菌(Streptococcus pyogenes):No.4
1、329〕を用い塗抹標本を作製した。乾燥後、アル
コ−ル固定を行い完全に乾燥させてから染色操作を行っ
た。EXAMPLES Example 1. [Preparation of sample] Two cases of two pure cultures, which are Gram-positive bacteria that are said to be difficult to stain with Gram stain [Staphylococcus aureus: No. 37,352,
Streptococcus pyogenes: No. Four
1,329] was used to prepare a smear. After drying, an alcohol was fixed and completely dried, and then a dyeing operation was performed.
【0042】 〔試液の調製〕 (1)前染色試液:20v/v%エタノール水溶液 クリスタルバイオレット 0.4v/v% N-ドデカノイルサルコシン酸Na 0.1v/v% Bis−Tris pH6.2となるように添加 (2)媒染試液:ヨウ素 2% 水酸化ナトリウム溶液 0.4% (3)脱色試液:アセトン 30v/v% エタノール 70v/v% (4)後染色試液:パイフェル液(和光純薬工業(株)社製)[0042] [Preparation of test solution] (1) Pre-staining reagent: 20v / v% ethanol aqueous solution Crystal violet 0.4v / v% N-dodecanoyl sarcosinate Na 0.1v / v% Bis-Tris Add to pH 6.2 (2) Mordant reagent: iodine 2% Sodium hydroxide solution 0.4% (3) Decolorization test solution: Acetone 30v / v% Ethanol 70v / v% (4) Post-dyeing reagent: Paifel liquid (manufactured by Wako Pure Chemical Industries, Ltd.)
【0043】〔染色処理〕
(1)前染色試液をサンプル上に満載し、室温で30秒間
反応させた。その後、水で静かに洗浄した。
(2)媒染試液をサンプル上に満載し、室温で30秒間反
応させた。その後、水で静かに洗浄した。
(3)脱色試液で室温で数秒間脱色し、水で静かに洗浄
した。
(4)パイフェル液をサンプル上に満載し、室温で10秒
間反応させた。水で静かに洗浄し自然乾燥後、鏡検し
た。その結果を表1に示す。また黄色ブドウ球菌No.
352の染色像を図1に示す。[Staining Treatment] (1) A pre-staining reagent solution was fully loaded on the sample and reacted at room temperature for 30 seconds. Then, it was washed gently with water. (2) A mordant reagent solution was loaded on the sample and allowed to react at room temperature for 30 seconds. Then, it was washed gently with water. (3) The sample was decolorized with the decolorizing reagent at room temperature for several seconds, and washed gently with water. (4) A sample of Paifel's solution was loaded on the sample and reacted at room temperature for 10 seconds. It was gently washed with water, air-dried and then examined with a microscope. The results are shown in Table 1. In addition, Staphylococcus aureus No.
The stained image of 352 is shown in FIG.
【0044】比較例1.(従来1液法)
〔サンプル作製〕実施例1と同様にして調製したものを
用いた。
〔試液及び染色操作〕「バーミーM染色」キット(武藤
化学(株)社製)を用い、キット添付の説明書に記載の
標準操作法に従って染色を行った。その結果を表1に合
わせて示す。また黄色ブドウ球菌No.352の染色像
を図2に示す。Comparative Example 1. (Conventional one-liquid method) [Sample preparation] The one prepared in the same manner as in Example 1 was used. [Reagent and Staining Operation] Using "Burmy M Staining" kit (manufactured by Muto Kagaku Co., Ltd.), staining was performed according to the standard operating method described in the instructions attached to the kit. The results are also shown in Table 1. In addition, Staphylococcus aureus No. The stained image of 352 is shown in FIG.
【0045】比較例2(従来2液法)
〔サンプル作製〕実施例1と同様にして調製したものを
用いた。
〔試液及び染色操作〕「グラム染色液B&Mワコー」キ
ット(和光純薬工業(株)社製)を用い、キットに添付
の説明書に記載の標準操作法に従って染色を行った。そ
の結果を表1に合わせて示す。また、黄色ブドウ球菌N
o.352の染色像を図3に示す。Comparative Example 2 (conventional two-liquid method) [Sample preparation] The sample prepared in the same manner as in Example 1 was used. [Reagent and dyeing operation] Using "Gram dye B & M Wako" kit (manufactured by Wako Pure Chemical Industries, Ltd.), dyeing was performed according to the standard operation method described in the instructions attached to the kit. The results are also shown in Table 1. Also, Staphylococcus aureus N
o. The stained image of 352 is shown in FIG.
【0046】[0046]
【表1】 [Table 1]
【0047】〔考察〕実施例1、比較例1及び2により
得られた、グラム染色により特に染まりにくい菌といわ
れる黄色ブドウ球菌No.37及びNo.352、化膿性連鎖球菌N
o.41及びNo.329の染色像を比較すると、表1及び図1〜
3の結果から明らかなように、黄色ブドウ球菌No.37、
並びに化膿性連鎖球菌No.41及びNo.329については染色
像に差が殆ど見られなかった。しかしながら、黄色ブド
ウ球菌No.352については、比較例1(従来1液法)によ
り得られた染色像のみが、少し赤く染まってしまい、ま
た染色面積が少なく(図2参照。)、判定が不明瞭とな
ることがわかった。[Discussion] Staphylococcus aureus Nos. 37 and 352, Streptococcus pyogenes N, which are obtained in Example 1 and Comparative Examples 1 and 2 and are said to be particularly difficult to stain by Gram's staining
Comparing the stained images of o.41 and No.329, Table 1 and FIG.
As is clear from the results of 3, Staphylococcus aureus No. 37,
In addition, there was almost no difference in the stained images of S. pyogenes No. 41 and No. 329. However, for Staphylococcus aureus No. 352, only the stained image obtained by Comparative Example 1 (conventional one-liquid method) was slightly reddish, and the stained area was small (see FIG. 2), and the judgment was unsuccessful. It turned out to be clear.
【0048】一方、実施例1(本発明に係る2液法)に
より得られた黄色ブドウ球菌No.352の染色像は、比較例
2(従来2液法)により得られた黄色ブドウ球菌No.352
の染色像よりもより青みの強い鮮明なものであった。On the other hand, the stained image of Staphylococcus aureus No. 352 obtained by Example 1 (two-component method according to the present invention) shows the Staphylococcus aureus No. 352 obtained by Comparative Example 2 (conventional two-component method). 352
It was clearer and more bluish than the stained image.
【0049】これらの結果から、本発明の前染色試液或
いはこれを構成試薬として含んでなるグラム染色用試薬
キットを用いることにより、従来のものよりも簡便に且
つ鮮明な染色像が得られることが判る。From these results, by using the pre-staining reagent solution of the present invention or the reagent kit for Gram stain containing the same as a constituent reagent, it is possible to obtain a clearer stained image more easily than the conventional one. I understand.
【0050】[0050]
【発明の効果】以上のことから明らかな如く、本発明
は、保存安定性に優れたグラム染色用前染色試液、これ
を構成試薬として含んでなるグラム染色用試薬キット、
及びこれらを用いるグラム染色の改良法を提供するもの
である。本発明を用いれば、従来のグラム染色よりも鮮
明な染色像が得られ、前染色試液の保存安定性も向上さ
せることができ、更に、前染色液が1液化されているた
め、自動機器への対応が可能となる等の優れた効果を奏
する。As is apparent from the above, the present invention provides a pre-staining reagent solution for Gram staining which is excellent in storage stability, a reagent kit for Gram staining containing the pre-staining reagent solution for Gram staining,
And an improved method of Gram staining using them. By using the present invention, a clearer dyeing image than conventional Gram's dyeing can be obtained and the storage stability of the pre-dyeing reagent solution can be improved. It has an excellent effect that it can be dealt with.
【図1】実施例1の方法により得られた、黄色ブドウ球
菌No.352のグラム染色像である。1 is a Staphylococcus aureus No. obtained by the method of Example 1. FIG. 352 is a Gram-stained image of 352.
【図2】比較例1の方法により得られた、黄色ブドウ球
菌No.352のグラム染色像である。FIG. 2 Staphylococcus aureus No. obtained by the method of Comparative Example 1 352 is a Gram-stained image of 352.
【図3】比較例2の方法により得られた、黄色ブドウ球
菌No.352のグラム染色像である。3 is a Staphylococcus aureus No. obtained by the method of Comparative Example 2. 352 is a Gram-stained image of 352.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 2G045 AA28 BA11 BA14 BB25 BB29 BB51 BB54 CB21 FA16 FB11 GC12 2G052 AA36 AD32 CA03 CA04 CA48 DA07 FA05 FA09 FC05 FC06 FD02 FD18 GA32 JA03 JA04 JA06 JA07 JA08 JA11 4B063 QA01 QQ06 QR51 QR66 QS36 QX01 ─────────────────────────────────────────────────── ─── Continued front page F term (reference) 2G045 AA28 BA11 BA14 BB25 BB29 BB51 BB54 CB21 FA16 FB11 GC12 2G052 AA36 AD32 CA03 CA04 CA48 DA07 FA05 FA09 FC05 FC06 FD02 FD18 GA32 JA03 JA04 JA06 JA07 JA08 JA11 4B063 QA01 QQ06 QR51 QR66 QS36 QX01
Claims (10)
活性剤とを含んでなる、グラム染色用前染色試液。1. A pre-staining reagent solution for Gram stain, which comprises crystal violet and an anionic surfactant.
ンスルホン酸塩、アルキル硫酸塩、アミノ酸系陰イオン
界面活性剤、オレイン酸塩、コール酸塩又はN-ドデカノ
イルサルコシン酸塩である、請求項1に記載の染色試
液。2. The anionic surfactant is alkylbenzene sulfonate, alkyl sulfate, amino acid-based anionic surfactant, oleate, cholate or N-dodecanoyl sarcosinate. The staining reagent solution described in 1.
サルコシン酸ナトリウム、N-アシルグルタミン酸ナトリ
ウム又はコール酸ナトリウムである、請求項1に記載の
染色試液。3. The dyeing reagent solution according to claim 1, wherein the anionic surfactant is sodium N-dodecanoylsarcosinate, sodium N-acylglutamate or sodium cholate.
活性剤とを含んでなるグラム染色用前染色試液を構成試
薬として含んでなる、グラム染色用試薬キット。4. A Gram staining reagent kit comprising a pre-staining reagent solution for Gram staining containing crystal violet and an anionic surfactant as a constituent reagent.
性有機溶媒を含んでなる脱色試液、及びサフラニン、石
炭酸フクシン又は塩基性フクシンを含んでなる後染色試
液を構成試薬として含んでなる、請求項4に記載の試薬
キット。5. A mordant reagent containing iodine, a decolorizing reagent containing a polar organic solvent, and a post-dyeing reagent containing safranine, fuchsin carbonate or basic fuchsin as constituent reagents. Item 4. The reagent kit according to Item 4.
ンスルホン酸塩、アルキル硫酸塩、アミノ酸系陰イオン
界面活性剤、オレイン酸塩、コール酸塩又はN-ドデカノ
イルサルコシン酸塩である、請求項4に記載の試薬キッ
ト。6. The anionic surfactant is alkylbenzene sulfonate, alkyl sulfate, amino acid-based anionic surfactant, oleate, cholate or N-dodecanoyl sarcosinate. Reagent kit according to.
サルコシン酸ナトリウム、N-アシルグルタミン酸ナトリ
ウム又はコール酸ナトリウムである、請求項4に記載の
試薬キット。7. The reagent kit according to claim 4, wherein the anionic surfactant is sodium N-dodecanoylsarcosinate, sodium N-acylglutamate or sodium cholate.
ルバイオレット溶液を含んでなる前染色試液で処理した
後、ヨウ素を含んでなる媒染試液で処理し、次いで極性
有機溶媒を含んでなる脱色試液で処理し、更にサフラニ
ン、石炭酸フクシン又は塩基性フクシンを含んでなる後
染色試液で処理することを特徴とする、グラム染色法。8. A sample is treated with a pre-staining reagent containing an anionic surfactant and a crystal violet solution, then with a mordant reagent containing iodine, and then with a decolorizing reagent containing a polar organic solvent. And a post-staining reagent solution containing safranine, fuchsin carbonate, or basic fuchsin.
ンスルホン酸塩、アルキル硫酸塩、アミノ酸系陰イオン
界面活性剤、オレイン酸塩、コール酸塩又はN-ドデカノ
イルサルコシン酸塩である、請求項8に記載のグラム染
色法。9. The anionic surfactant is alkylbenzene sulfonate, alkyl sulfate, amino acid-based anionic surfactant, oleate, cholate or N-dodecanoyl sarcosinate. Gram stain method described in.
ルサルコシン酸ナトリウム、N-アシルグルタミン酸ナト
リウム又はコール酸ナトリウムである、請求項8に記載
のグラム染色法。10. The Gram staining method according to claim 8, wherein the anionic surfactant is sodium N-dodecanoylsarcosinate, sodium N-acylglutamate or sodium cholate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001375203A JP3997773B2 (en) | 2001-12-10 | 2001-12-10 | Gram staining reagent, reagent kit, and Gram staining method using the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001375203A JP3997773B2 (en) | 2001-12-10 | 2001-12-10 | Gram staining reagent, reagent kit, and Gram staining method using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003169694A true JP2003169694A (en) | 2003-06-17 |
| JP3997773B2 JP3997773B2 (en) | 2007-10-24 |
Family
ID=19183616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001375203A Expired - Fee Related JP3997773B2 (en) | 2001-12-10 | 2001-12-10 | Gram staining reagent, reagent kit, and Gram staining method using the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3997773B2 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104374618A (en) * | 2014-10-20 | 2015-02-25 | 山东省果树研究所 | Plant chromosome tablet observation method |
| JP2017099328A (en) * | 2015-12-01 | 2017-06-08 | 日水製薬株式会社 | Post-staining reagent for Gram dyeing and Gram dyeing method |
| CN108181155A (en) * | 2012-03-19 | 2018-06-19 | 文塔纳医疗系统公司 | Improve the Gram-staining process of the decoloration to crystal violet-Surgidine of gramnegative bacterium |
| CN108593392A (en) * | 2018-01-26 | 2018-09-28 | 广州江元医疗科技有限公司 | A kind of vaginal fluid dyeing liquor and preparation method thereof |
| EP3656218A1 (en) * | 2018-11-23 | 2020-05-27 | Lonza Ltd | Method for testing the result of a filling process of vials |
| WO2021072080A1 (en) * | 2019-10-11 | 2021-04-15 | Beckman Coulter, Inc. | Method and composition for staining and sample processing |
| CN113133513A (en) * | 2021-04-30 | 2021-07-20 | 西北农林科技大学 | Nano bionic enhanced gram-positive bacterium capture-separation agent and preparation method and application thereof |
| CN113933135A (en) * | 2021-10-13 | 2022-01-14 | 郑州安图生物工程股份有限公司 | Gram staining kit and method for automatic drop staining |
| WO2025201644A1 (en) * | 2024-03-27 | 2025-10-02 | Bio-Gram Microbiology Gmbh | Gram staining method |
-
2001
- 2001-12-10 JP JP2001375203A patent/JP3997773B2/en not_active Expired - Fee Related
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108181155B (en) * | 2012-03-19 | 2020-11-27 | 文塔纳医疗系统公司 | Improved Gram stain method for decolorization of crystal violet-iodine complexes of Gram-negative bacteria |
| CN108181155A (en) * | 2012-03-19 | 2018-06-19 | 文塔纳医疗系统公司 | Improve the Gram-staining process of the decoloration to crystal violet-Surgidine of gramnegative bacterium |
| CN104374618A (en) * | 2014-10-20 | 2015-02-25 | 山东省果树研究所 | Plant chromosome tablet observation method |
| JP2017099328A (en) * | 2015-12-01 | 2017-06-08 | 日水製薬株式会社 | Post-staining reagent for Gram dyeing and Gram dyeing method |
| CN108593392A (en) * | 2018-01-26 | 2018-09-28 | 广州江元医疗科技有限公司 | A kind of vaginal fluid dyeing liquor and preparation method thereof |
| CN108593392B (en) * | 2018-01-26 | 2020-09-04 | 广州江元医疗科技有限公司 | Vaginal secretion staining solution and preparation method thereof |
| EP3656218A1 (en) * | 2018-11-23 | 2020-05-27 | Lonza Ltd | Method for testing the result of a filling process of vials |
| WO2021072080A1 (en) * | 2019-10-11 | 2021-04-15 | Beckman Coulter, Inc. | Method and composition for staining and sample processing |
| US12517018B2 (en) | 2019-10-11 | 2026-01-06 | Beckman Coulter, Inc. | Method and composition for staining and sample processing |
| CN113133513A (en) * | 2021-04-30 | 2021-07-20 | 西北农林科技大学 | Nano bionic enhanced gram-positive bacterium capture-separation agent and preparation method and application thereof |
| CN113133513B (en) * | 2021-04-30 | 2023-07-18 | 西北农林科技大学 | A nano-bionic enhanced Gram-positive bacteria capture-separation agent and its preparation method and application |
| CN113933135A (en) * | 2021-10-13 | 2022-01-14 | 郑州安图生物工程股份有限公司 | Gram staining kit and method for automatic drop staining |
| CN113933135B (en) * | 2021-10-13 | 2024-01-26 | 郑州安图生物工程股份有限公司 | Gram staining kit and staining method for automatic drop staining |
| WO2025201644A1 (en) * | 2024-03-27 | 2025-10-02 | Bio-Gram Microbiology Gmbh | Gram staining method |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3997773B2 (en) | 2007-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Williams-Smith et al. | Changes in apparent pH on freezing aqueous buffer solutions and their relevance to biochemical electron-paramagnetic-resonance spectroscopy | |
| JP2003169694A (en) | Gram's staining reagent solution, gram's staining reagent kit, and gram's staining method using the same | |
| JP6874888B1 (en) | Staining solution for urine sediment | |
| EP0167395B1 (en) | Method for solubilizing microbial coatings and protein complexes | |
| JP6688057B2 (en) | Post-dyeing reagent for Gram stain and Gram stain method | |
| JPH0642838B2 (en) | Improved dyeing method for mycobacteria | |
| Bartholomew et al. | Relationship of cell wall staining to gram differentiation | |
| US5827680A (en) | Three reagent gram staining method and kit | |
| JP2516841B2 (en) | Extraction method | |
| US5777098A (en) | DNA purification procedure | |
| DE68919982T2 (en) | Stabilized extracting composition containing a reducing agent containing sulfydril and its use for the determination of chlamydia and gonococci. | |
| US20170096634A1 (en) | Mycobacteria pre-analytic reagent | |
| US5393661A (en) | Three reagent gram staining method and kit | |
| DE68921533T2 (en) | Use of a protease for the extraction of antigens from Chlamydia, gonococci and herpes. | |
| No et al. | In vitro maturation using porcine follicular fluid-derived exosomes as an alternative to the conventional method | |
| JP7341144B2 (en) | Phenol-free acid-fast staining composition and its use | |
| US4916061A (en) | Gram staining method and kit | |
| US20040089847A1 (en) | Stain solution which is devoid of phenol | |
| CA2179368A1 (en) | Three reagent gram staining method and kit | |
| WO2005038044A1 (en) | Method of treating cells | |
| JP3306534B2 (en) | Protein detection method and protein detection kit | |
| JPH0233358B2 (en) | GURAMUSEN SHOKUHOHO | |
| Hanks | Retention and differentiation of carbolfuchsin-stained mycobacteria in diagnostic films | |
| Wipe | A. Morphological Observations | |
| THOMA | Studies on the Gram Stain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040906 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070417 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070615 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070717 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070730 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3997773 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100817 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100817 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130817 Year of fee payment: 6 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |